Results 181 to 190 of about 918,150 (305)

Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis. [PDF]

open access: yesAm J Respir Crit Care Med
McNair E   +10 more
europepmc   +1 more source

Interleukin‐12: Central Roles in Immune Regulation and Disease Therapy

open access: yesImmunology &Cell Biology, EarlyView.
IL‐12 levels are tightly regulated to balance effective protective immunity against infections and cancer with the risk of excessive inflammation and autoimmune disease. Both insufficient and excessive IL‐12 activity can therefore be detrimental, highlighting the importance of precisely controlling its production and signaling. ABSTRACT Interleukin‐12 (
Anthi Psoma, Geert van den Bogaart
wiley   +1 more source

Novel RT‒qPCR-based blood signatures for the diagnosis of pulmonary tuberculosis. [PDF]

open access: yesSci Rep
Horta T   +10 more
europepmc   +1 more source

Anthracofibrosis: an under‐recognised mimic of malignancy and tuberculosis in a migrant population

open access: yesInternal Medicine Journal, EarlyView.
Abstract Anthracosis, usually regarded as a benign and uncommon bronchoscopic finding, was identified in 108 (9.9%) of 1154 bronchoscopy procedures at two Australian hospitals, with almost a third showing bronchial narrowing consistent with anthracofibrosis.
Wai Yiu   +2 more
wiley   +1 more source

Primary pulmonary leiomyosarcoma in a patient with disseminated pulmonary tuberculosis and constrictive pericarditis. [PDF]

open access: yesRespir Med Case Rep
Van Der Westhuizen S   +5 more
europepmc   +1 more source

Improving timeliness of lung cancer care through a rapid assessment clinic

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Early diagnosis and treatment of lung cancer improve survival. Guidelines from Australia and worldwide stipulate timeframes of care from referral. The Rapid Lung Assessment Clinic (RLAC) was established to fast‐track the diagnostic and treatment pathway, with a subsequent quality improvement initiative based on the initial analysis ...
Shakti V. Dabholkar   +6 more
wiley   +1 more source

Asthma Incidence and Risk Factors in Tuberculosis Survivors: A Longitudinal Analysis of National Health Data

open access: yes
Clinical &Experimental Allergy, EarlyView.
Jong Geol Jang   +6 more
wiley   +1 more source

Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement

open access: yesInternal Medicine Journal, EarlyView.
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy